As filed with the Securities and Exchange Commission on November 9, 2018
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
Verastem, Inc.
(Exact name of registrant as specified in its charter)
Delaware |
|
27-3269467 |
(State or other jurisdiction |
|
(I.R.S Employer Identification No.) |
117 Kendrick St., Suite 500 |
|
02494 |
(Address of Principal Executive Offices) |
|
(Zip Code) |
2014 Inducement Award Program
(Full title of the plan)
Robert Forrester
President and Chief Executive Officer
Verastem, Inc.
117 Kendrick St., Suite 500
Needham, MA 02494
(781) 292-4200
(Name, address, and telephone number, including area code, of agent for service)
With copies to:
Marko S. Zatylny
Ropes & Gray LLP
Prudential Tower
800 Boylston Street
Boston, MA 02199
(617) 951-7000
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of large accelerated filer, accelerated filer, smaller reporting company, and emerging growth company in Rule 12b-2 of the Exchange Act.
Large accelerated filer o |
|
Accelerated filer x |
|
|
|
Non-accelerated filer o |
|
Smaller reporting company x |
|
|
|
|
|
Emerging growth company o |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. o
CALCULATION OF REGISTRATION FEE
|
|
|
|
|
|
|
|
|
| |||
Title of each class of |
|
Amount to be |
|
Proposed |
|
Proposed maximum |
|
Amount of |
| |||
Common Stock, $0.0001 par value per share |
|
1,700,000 shares |
|
$ |
5.04 |
|
$ |
8,568,000 |
|
$ |
1,038.44 |
|
(1) This Registration Statement covers an aggregate of 1,700,000 shares of the Registrants Common Stock, par value $0.0001 per share (the Common Stock), that may be issued pursuant to awards granted or to be granted in accordance with Nasdaq Listing Rule 5635(c)(4), as an inducement material to an individuals entering into employment with the Registrant. In addition, pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the Securities Act), this Registration Statement also covers such additional shares of Common Stock as may be issued to prevent dilution from stock splits, stock dividends and similar transactions.
(2) Pursuant to Rules 457(c) and 457(h)(1) under the Securities Act, the proposed maximum offering price per share and the maximum aggregate offering price for the shares have been calculated solely for the purpose of computing the registration fee on the basis of the average high and low prices of the Common Stock as reported by the Nasdaq Global Market on November 5, 2018 to be $5.15 and $4.93, respectively.
EXPLANATORY NOTE
This Registration Statement on Form S-8 is being filed to register an additional 1,700,000 shares under the Registrants 2014 Inducement Award Program. Pursuant to Instruction E to Form S-8, the Registrant incorporates by reference, except to the extent supplemented, amended or superseded by the information set forth herein, into this Registration Statement the entire contents of its Registration Statement on Form S-8 (File No. 333-201075) filed with the Securities and Exchange Commission on December 19, 2014.
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 8. Exhibits.
See the Exhibit Index following the signature page.
EXHIBIT INDEX
Exhibit |
|
Description |
|
|
|
4.1 |
|
|
|
|
|
4.2 |
|
|
|
|
|
4.3 |
|
|
|
|
|
4.4 |
|
|
|
|
|
5.1 |
|
|
|
|
|
23.1 |
|
|
|
|
|
23.2 |
|
|
|
|
|
24.1 |
|
Each person whose signature appears below constitutes and appoints Robert Forrester and Daniel Paterson, and each of them singly, either of whom may act without the joinder of the other, as his or her true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him or her and in his or her name, place, and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement on Form S-8, and to file the same, with all exhibits thereto, and other documents in connection therewith with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them singly, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or either of them, or their or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed below by the following persons in the capacities and on the dates indicated.
SIGNATURES |
|
TITLE |
|
DATE |
|
|
|
|
|
|
|
/s/ Robert Forrester |
|
President, Chief Executive Officer |
|
November 9, 2018 |
|
Robert Forrester |
|
(Principal executive officer) and Director |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Robert Gagnon |
|
Chief Financial Officer |
|
November 9, 2018 |
|
Robert Gagnon |
|
(Principal financial and accounting officer) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Timothy Barberich |
|
Director |
|
November 9, 2018 |
|
Timothy Barberich |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Michael Kauffman |
|
Director |
|
November 9, 2018 |
|
Michael Kauffman, M.D., Ph.D. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Alison Lawton |
|
Director |
|
November 9, 2018 |
|
Alison Lawton |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Gina Consylman |
|
Director |
|
November 9, 2018 |
|
Gina Consylman |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Eric Rowinsky |
|
Director |
|
November 9, 2018 |
|
Eric Rowinsky, M.D. |
|
|
|
|
|
/s/ Brian Stuglik |
|
Director |
|
November 9, 2018 |
|
Brian Stuglik |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Bruce Wendel |
|
Director |
|
November 9, 2018 |
|
Bruce Wendel |
|
|
|
|
|
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Needham, Commonwealth of Massachusetts on November 9, 2018.
|
VERASTEM, INC. | |
|
| |
|
|
|
|
By: |
/s/ Robert Forrester |
|
|
Robert Forrester |
|
|
President and Chief Executive Officer |
ROPES & GRAY LLP | |
BOSTON, MA 02199-3600 |
November 9, 2018
Verastem, Inc.
117 Kendrick, Suite 500
Needham, MA 02494
Ladies and Gentlemen:
This opinion letter is furnished to you in connection with the registration statement on Form S-8 (the Registration Statement), filed by Verastem, Inc., a Delaware corporation (the Company), on the date hereof, with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the Securities Act), for the registration of 1,700,000 shares of Common Stock, $0.0001 par value, of the Company (the Shares). The Shares are issuable under the Companys 2014 Inducement Award Program (the Program).
We are familiar with the actions taken by the Company in connection with the establishment of the Program. We have examined such certificates, documents and records and have made such investigation of fact and such examination of law as we have deemed appropriate in order to enable us to render the opinions set forth herein. In conducting such investigation, we have relied, without independent verification, upon certificates of officers of the Company, public officials and other appropriate persons.
The opinions expressed below are limited to the Delaware General Corporation Law.
Based upon and subject to the foregoing, we are of the opinion that the Shares have been duly authorized and, when the Shares have been issued and sold in accordance with the terms of the respective inducement award agreements established for the Program, the Shares will be validly issued, fully paid and nonassessable.
We hereby consent to the filing of this opinion letter as an exhibit to the Registration Statement. In giving such consent, we do not thereby admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations thereunder.
Very truly yours,
/s/ Ropes & Gray LLP
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement (Form S-8) pertaining to the 2014 Inducement Award Program of Verastem, Inc. of our reports dated March 13, 2018, with respect to the consolidated financial statements of Verastem, Inc. and the effectiveness of internal control over financial reporting of Verastem, Inc. included in its Annual Report (Form 10-K) for the year ended December 31, 2017, filed with the Securities and Exchange Commission.
|
/s/ Ernst & Young |
Boston, Massachusetts
November 9, 2018